Phase 1 Solid Tumors Refractory to Standard Therapy Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Interventional Study to Evaluate the Combination of Palbociclib + Sunitinib as a Treatment for Advanced Solid Tumors

Solid Tumors Refractory to Standard Therapy

Rabin Medical Center100 enrolled1 locationNCT06940349

Recruiting

Phase 1Phase 2

AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors

Solid TumorSolid Tumor, AdultSolid Tumor Cancer+4 more

Avelos Therapeutics Inc.36 enrolled3 locationsNCT06911333

Recruiting

Phase 1

A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

Pancreas CancerSolid Tumor CancerHCC - Hepatocellular Carcinoma+6 more

LaunXP Biomedical Co., Ltd.24 enrolled2 locationsNCT06883539